Atlas Trials

Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation

Clinical trial NCT03402295 · COMPLETED

Trial details

NCT number
NCT03402295
Sponsor
Grupo de Estudos Multicentricos em Onco-Hematologia
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple MyelomaEffects of Chemotherapy
Start date
2009-06-15
Primary completion
2014-06-15
Enrollment
311

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.